Laboratory findings in SARS-CoV-2 infections: State of the art
SUMMARY OBJECTIVE The scientific community is constantly assessing the clinical and laboratory manifestations of COVID-19 in the organism. In view of the fragmentation of the large amount of information, knowledge gaps in relation to laboratory markers, and scarcity of papers in Portuguese, we propose a Literature review on laboratory changes observed in patients infected with SARS-CoV-2. METHODS Analysis of articles published between December 2019 and May 2020 on the PubMed and SciELO databases. The articles were identified, filtered, and evaluated based on the approach to the subject, language, and impact. Then, the articles were subjected to a thorough reading, in full, by 4 (four) independent researchers. RESULTS Leukopenia and lymphopenia were included in most studies, even in case definitions. Platelet count and platelet-lymphocyte ratio, at peak platelet, were associated with advanced age and longer hospital stay. Eosinopenia showed a sensitivity of 74.7% and specificity of 68.7% and, together with increased CRP, these are one of the future prospects for screening for disease. A high level of procalcitonin may indicate bacterial co-infection, leading to a worse prognosis. COVID-19 manifests itself with increased levels of many inflammatory markers such as IL-1, IL-2, IL-6, IL-7, IL-12, IP10, IFN-γ, MIP1A, MCP1, GSCF, TNF-α, and MCP1/CCL2, as well as LDH, ESR, D-dimer, CK, ALT, and AST. CONCLUSION There is a need for further studies on the new SARS-CoV-2. So far, there is no consensus regarding laboratory findings and their usefulness, whether as a prognostic marker, mortality, or disease severity.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Associação Médica Brasileira
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801152 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0104-42302020000801152 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0104-423020200008011522020-09-09Laboratory findings in SARS-CoV-2 infections: State of the artPereira,Miguel Augusto MartinsBarros,Isabella Carolina de AlmeidaJacob,Ana Luiza VeríssimoAssis,Mayara Lopes deKanaan,SalimKang,Hye Chung Coronavirus Infections Betacoronavirus Blood Cell Count Leukocyte Count SUMMARY OBJECTIVE The scientific community is constantly assessing the clinical and laboratory manifestations of COVID-19 in the organism. In view of the fragmentation of the large amount of information, knowledge gaps in relation to laboratory markers, and scarcity of papers in Portuguese, we propose a Literature review on laboratory changes observed in patients infected with SARS-CoV-2. METHODS Analysis of articles published between December 2019 and May 2020 on the PubMed and SciELO databases. The articles were identified, filtered, and evaluated based on the approach to the subject, language, and impact. Then, the articles were subjected to a thorough reading, in full, by 4 (four) independent researchers. RESULTS Leukopenia and lymphopenia were included in most studies, even in case definitions. Platelet count and platelet-lymphocyte ratio, at peak platelet, were associated with advanced age and longer hospital stay. Eosinopenia showed a sensitivity of 74.7% and specificity of 68.7% and, together with increased CRP, these are one of the future prospects for screening for disease. A high level of procalcitonin may indicate bacterial co-infection, leading to a worse prognosis. COVID-19 manifests itself with increased levels of many inflammatory markers such as IL-1, IL-2, IL-6, IL-7, IL-12, IP10, IFN-γ, MIP1A, MCP1, GSCF, TNF-α, and MCP1/CCL2, as well as LDH, ESR, D-dimer, CK, ALT, and AST. CONCLUSION There is a need for further studies on the new SARS-CoV-2. So far, there is no consensus regarding laboratory findings and their usefulness, whether as a prognostic marker, mortality, or disease severity.info:eu-repo/semantics/openAccessAssociação Médica BrasileiraRevista da Associação Médica Brasileira v.66 n.8 20202020-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801152en10.1590/1806-9282.66.8.1152 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Pereira,Miguel Augusto Martins Barros,Isabella Carolina de Almeida Jacob,Ana Luiza Veríssimo Assis,Mayara Lopes de Kanaan,Salim Kang,Hye Chung |
spellingShingle |
Pereira,Miguel Augusto Martins Barros,Isabella Carolina de Almeida Jacob,Ana Luiza Veríssimo Assis,Mayara Lopes de Kanaan,Salim Kang,Hye Chung Laboratory findings in SARS-CoV-2 infections: State of the art |
author_facet |
Pereira,Miguel Augusto Martins Barros,Isabella Carolina de Almeida Jacob,Ana Luiza Veríssimo Assis,Mayara Lopes de Kanaan,Salim Kang,Hye Chung |
author_sort |
Pereira,Miguel Augusto Martins |
title |
Laboratory findings in SARS-CoV-2 infections: State of the art |
title_short |
Laboratory findings in SARS-CoV-2 infections: State of the art |
title_full |
Laboratory findings in SARS-CoV-2 infections: State of the art |
title_fullStr |
Laboratory findings in SARS-CoV-2 infections: State of the art |
title_full_unstemmed |
Laboratory findings in SARS-CoV-2 infections: State of the art |
title_sort |
laboratory findings in sars-cov-2 infections: state of the art |
description |
SUMMARY OBJECTIVE The scientific community is constantly assessing the clinical and laboratory manifestations of COVID-19 in the organism. In view of the fragmentation of the large amount of information, knowledge gaps in relation to laboratory markers, and scarcity of papers in Portuguese, we propose a Literature review on laboratory changes observed in patients infected with SARS-CoV-2. METHODS Analysis of articles published between December 2019 and May 2020 on the PubMed and SciELO databases. The articles were identified, filtered, and evaluated based on the approach to the subject, language, and impact. Then, the articles were subjected to a thorough reading, in full, by 4 (four) independent researchers. RESULTS Leukopenia and lymphopenia were included in most studies, even in case definitions. Platelet count and platelet-lymphocyte ratio, at peak platelet, were associated with advanced age and longer hospital stay. Eosinopenia showed a sensitivity of 74.7% and specificity of 68.7% and, together with increased CRP, these are one of the future prospects for screening for disease. A high level of procalcitonin may indicate bacterial co-infection, leading to a worse prognosis. COVID-19 manifests itself with increased levels of many inflammatory markers such as IL-1, IL-2, IL-6, IL-7, IL-12, IP10, IFN-γ, MIP1A, MCP1, GSCF, TNF-α, and MCP1/CCL2, as well as LDH, ESR, D-dimer, CK, ALT, and AST. CONCLUSION There is a need for further studies on the new SARS-CoV-2. So far, there is no consensus regarding laboratory findings and their usefulness, whether as a prognostic marker, mortality, or disease severity. |
publisher |
Associação Médica Brasileira |
publishDate |
2020 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801152 |
work_keys_str_mv |
AT pereiramiguelaugustomartins laboratoryfindingsinsarscov2infectionsstateoftheart AT barrosisabellacarolinadealmeida laboratoryfindingsinsarscov2infectionsstateoftheart AT jacobanaluizaverissimo laboratoryfindingsinsarscov2infectionsstateoftheart AT assismayaralopesde laboratoryfindingsinsarscov2infectionsstateoftheart AT kanaansalim laboratoryfindingsinsarscov2infectionsstateoftheart AT kanghyechung laboratoryfindingsinsarscov2infectionsstateoftheart |
_version_ |
1756410077007314944 |